SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-001705
Filing Date
2022-01-04
Accepted
2022-01-04 16:16:01
Documents
13
Period of Report
2022-01-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d283972d8k.htm   iXBRL 8-K 23654
2 EX-99.1 d283972dex991.htm EX-99.1 21882
  Complete submission text file 0001193125-22-001705.txt   183002

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA annx-20220104.xsd EX-101.SCH 2884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20220104_lab.xml EX-101.LAB 19655
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20220104_pre.xml EX-101.PRE 12309
7 EXTRACTED XBRL INSTANCE DOCUMENT d283972d8k_htm.xml XML 3592
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 22506106
SIC: 2834 Pharmaceutical Preparations